Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Magee, LA; Ornstein, MP; von Dadelszen, P (1999)
Publisher: BMJ Publishing Group
Languages: English
Types: Article
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1 National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1691­712.
    • 2 Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257­65.
    • 3 Steyn DW, Odendaal HJ. Randomised controlled trial of ketanserin and aspirin in prevention of pre­eclampsia. Lancet 1997;350:1267­71.
    • 4 Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol 1978;53:489­94.
    • 5 Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587­9.
    • 6 Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society consensus conference. 3. Pharmacologic treatment of hypertensive disorders in pregnancy. Can Med Assoc J 1997;157: 1245­54.
    • 7 Duley L. Hospitalisation for non­proteinuric pregnancy hypertension. In: Pregnancy and childbirth module. Cochrane Collaboration. Cochrane Library, Issue 1. Oxford: Update Software, 1993.
    • 8 Tuffnell DJ, Lilford RJ, Buchan PC, Prendiville VM, Tuffnell AJ, Holgate MP, et al. Randomised controlled trial of day care for hypertension in pregnancy. Lancet 1992;339:224­7.
    • 9 Crowther CA. Strict bed rest vs ambulation in the management of patients with proteinuric hypertension in pregnancy. In: Pregnancy and childbirth module. Cochrane Collaboration. Cochrane Library, Issue 1. Oxford: Update Software, 1993.
    • 10 Matthews DD, Agarwal V, Shuttleworth TP. A randomized controlled trial of complete bed rest versus ambulation in the management of proteinuric hypertension during pregnancy. Br J Obstet Gynaecol 1982;89:128­31.
    • 11 Rothberg AD, Shuenyane E, Sefuba M. Psychosocial support for mothers with pregnancy­related hypertension: effect on birthweight. Pediatr Rev Commun 1991;6:13­20.
    • 12 Somers PH, Gevirtz RN, Jasin SE. The efficacy of biobehavioral and compliance interventions in the adjunctive treatment of mild pregnancyinduced hypertension. Biofeedback Self­Regul 1989;14:309­18.
    • 13 Menzies DN. Controlled trial of chlorothiazide in treatment of early preeclampsia. BMJ 1964;1:739­42.
    • 14 Walker JJ, Crooks A, Erwin L, Calder AA. Labetalol in pregnancy­induced hypertension: fetal and maternal effects. In: Reily A, Symonds EM, eds. International Congress Series 591. Excerpta Med 1982;148­60.
    • 15 Bott­Kanner G, Hirsch M, Friedman S, Boner G, Ovadia J, Merlob P, et al. Antihypertensive therapy in the management of hypertension in pregnancy-a clinical double­blind study of pindolol. Clin Exp Hypertension Pregnancy 1992;B11:207­20.
    • 16 Wide­Swensson DH, Ingemarsson I, Lunell NO, Forman A, Skajaa K, Lindberg B, et al. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo­controlled study. Am J Obstet Gynecol 1995;173:872­8.
    • 17 Cockburn J, Ounsted M, Moar VA, Redman CWG. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;647­9.
    • 18 Reynolds B, Butters L, Evans J, Adams T, Rubin PC. First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child 1984;59:1061­3.
    • 19 Collins R, Duley L. Any antihypertensive therapy for pregnancy hypertension. In: Pregnancy and childbirth module. Cochrane Collaboration. Cochrane Library, Issue 1. Oxford: Update Softrware, 1994.
    • 20 Lardoux H, Blazquez G, Leperlier E, Gerard J. Essai ouvert, comparatif, avec tirage au sort pour le traitment de l'HTA gravidique moderee: methyldopa, acebutolol, labetalol. Arch Mal Coeur 1988(suppl HTA);81:137­40.
    • 21 El­Qarmalawi AM, Morsy AH, Al­Fadly A, Obeid A, Hashem M. Labetalol vs methyldopa in the treatment of pregnancy­induced hypertension. Int J Gynaecol Obstet 1995;49:125­30.
    • 22 Oumachigui A, Verghese M, Balachander J. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy­induced hypertension. Indian Heart J 1992;44:39­41.
    • 23 Hjertberg R, Faxelius G, Lagercrantz H. Neonatal adaptation in hypertensive pregnancy-a study of labetalol vs hydralazine treatment. J Perinat Med 1993;21:69­75.
    • 24 Paran E, Holzberg G, Mazor M, Zmora E, Insler V. Beta­adrenergic blocking agents in the treatment of pregnancy­induced hypertension. Int J Clin Pharmacol Ther 1995;33:119­23.
    • 25 Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Randomised controlled trial of methyldopa and isradipine in preeclampsia-effects on uteroplacental and fetal hemodynamics. J Perinat Med 1996;24:177­84.
    • 26 Marlettini MG, Crippa S, Morselli­Labate AM, Contarini A, Orlandi C. Randomised comparison of calcium antagonists and beta­blockers in the treatment of pregnancy­induced hypertension. Curr Ther Res 1990;45:684­94.
    • 27 Wide­Swensson D, Montan S, Arulkumaran S, Ingemarsson I, Ratnam SS. Effect of methyldopa and isradipine on fetal heart rate pattern assessed by computerized cardiotocography in human pregnancy. Am J Obstet Gynecol 1993;169:1581­5.
    • 28 Voto LS, Zin C, Neira J, Lapidus AM, Margulies M. Ketanserin versus á­methyldopa in the treatment of hypertension during pregnancy: a preliminary report. J Cardiovasc Pharmacol 1987;10(suppl 3):101­3S.
    • 29 Horvath JS, Phippard A, Korda A, Henderson­Smart DJ, Child A, Tiller DJ. Clonidine hydrochloride-a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1985;66:634­8.
    • 30 Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171:818­22.
    • 31 Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJvW. Aggressive or expectant management for patients with severe preeclampsia between 28­34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990;76:1070­5.
    • 32 Olah KS, Redman CWG, Gee H. Management of severe, early pre­eclampsia: is conservative management justified? Eur J Obstet Gynecol Reprod Biol 1993;51:175­80.
    • 33 Griffis KR, Martin JN, Palmer SM, Martin RW, Morrison JC. Utilization of hydralazine or alpha­methyldopa for the management of early puerperal hypertension. Am J Perinatol 1989;6:437­41.
    • 34 Bhorat IE, Naidoo DP, Rout CC, Moodley J. Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine. Am J Obstet Gynecol 1993;168:1292­6.
    • 35 Jegasothy R, Paranthaman S. Sublingual nifedipine compared with intravenous hydralazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. J Obstet Gynaecol Res 1996;22:21­4.
    • 36 Howarth GR, Seris A, Venter C, Pattinson RC. A randomized controlled pilot study comparing urapidil to dihydralazine in the management of severe hypertension in pregnancy. Hypertension Pregnancy 1997;16: 213­21.
    • 37 Ales K. Magnesium plus nifedipine. Am J Obstet Gynecol 1990;162;288.
    • 38 Brown MA, McCowan LME, North RA, Walters BN. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy? Med J Aust 1997;166:640­3.
    • 39 Gülmezoglu AM, Hofmeyr GJ, Oosthuisen MMJ. Antioxidants in the treatment of severe pre­eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 1997;104:689­96.
    • 40 Moodley J, Gouws E. A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy. Br J Obstet Gynaecol 1992;99:727­30.
    • 41 Department of Health. Confidential enquiries into maternal death in the United Kingdom 1985­87. London: HMSO, 1991.
    • 42 Wallace CH, Leveno KJ, Cunningham FG, Giesecke AH, Shearer VE, Sidawi JE. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol 1996;86:193­9.
    • 43 Ramanathan J, Sibai BM, Mabie W, Chauhan D, Guiz AG. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. Am J Obstet Gynecol 1988;159:650­4.
    • 44 Barton JR, Hiett AK, Conover WB. The use of nifedipine during the postpartum period in patients with severe preeclampsia. Am J Obstet Gynecol 1990;162:788­92.
    • 45 Griffis KR, Martin JN, Palmer SM, Martin RW, Morrison JC. Utilization of hydralazine or alpha­methyldopa for the management of early puerperal hypertension. Am J Perinatol 1989;6:437­41.
    • 46 Fidler J, Smith V, de Swiet M. A randomized study comparing timolol and methyldopa in hospital treatment of puerperal hypertension. Br J Obstet Gynaecol 1982;89:1031­4.
    • 47 Walters BNJ, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci 1986;71:589­94.
    • 48 Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 4th ed. Baltimore: Williams and Wilkins, 1994.
    • 49 Giannina G, Belfort MA. Use of transcranial and orbital Doppler sonography in normal pregnancy and pre­eclampsia: a review. J Soc Obstet Gynaecol 1997;19:1249­63.
    • (Accepted 12 March 1999)
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article